Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31320608)

  • 1. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
    Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
    Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.
    Anantha RW; Alcivar AL; Ma J; Cai H; Simhadri S; Ule J; König J; Xia B
    PLoS One; 2013; 8(4):e61368. PubMed ID: 23585894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (
    Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C
    Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation.
    Isono M; Niimi A; Oike T; Hagiwara Y; Sato H; Sekine R; Yoshida Y; Isobe SY; Obuse C; Nishi R; Petricci E; Nakada S; Nakano T; Shibata A
    Cell Rep; 2017 Jan; 18(2):520-532. PubMed ID: 28076794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.
    Mouche A; Archambeau J; Ricordel C; Chaillot L; Bigot N; Guillaudeux T; Grenon M; Pedeux R
    Cell Death Differ; 2019 Nov; 26(11):2344-2357. PubMed ID: 30804473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.
    Drané P; Brault ME; Cui G; Meghani K; Chaubey S; Detappe A; Parnandi N; He Y; Zheng XF; Botuyan MV; Kalousi A; Yewdell WT; Münch C; Harper JW; Chaudhuri J; Soutoglou E; Mer G; Chowdhury D
    Nature; 2017 Mar; 543(7644):211-216. PubMed ID: 28241136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
    Bakkenist CJ; Lee JJ; Schmitz JC
    Clin Colorectal Cancer; 2018 Dec; 17(4):255-257. PubMed ID: 30316683
    [No Abstract]   [Full Text] [Related]  

  • 9. FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function.
    Tang M; Feng X; Pei G; Srivastava M; Wang C; Chen Z; Li S; Zhang H; Zhao Z; Li X; Chen J
    Cell Rep; 2020 Aug; 32(6):108018. PubMed ID: 32783940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice.
    Gupta A; Hunt CR; Hegde ML; Chakraborty S; Chakraborty S; Udayakumar D; Horikoshi N; Singh M; Ramnarain DB; Hittelman WN; Namjoshi S; Asaithamby A; Hazra TK; Ludwig T; Pandita RK; Tyler JK; Pandita TK
    Cell Rep; 2014 Jul; 8(1):177-89. PubMed ID: 24953651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.
    Zhang A; Peng B; Huang P; Chen J; Gong Z
    J Biol Chem; 2017 Apr; 292(16):6461-6467. PubMed ID: 28213517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
    Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B
    BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.
    Hui B; Zhou C; Xu Y; Wang R; Dong Y; Zhou Y; Ding J; Zhang X; Xu J; Gu Y
    J Nanobiotechnology; 2024 Feb; 22(1):62. PubMed ID: 38360615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF4 regulates DNA double-strand break repair in a cell cycle-dependent manner.
    Kuo CY; Li X; Stark JM; Shih HM; Ann DK
    Cell Cycle; 2016; 15(6):787-98. PubMed ID: 26766492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
    Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X
    Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nup153 and Nup50 promote recruitment of 53BP1 to DNA repair foci by antagonizing BRCA1-dependent events.
    Mackay DR; Howa AC; Werner TL; Ullman KS
    J Cell Sci; 2017 Oct; 130(19):3347-3359. PubMed ID: 28751496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM and CDK2 control chromatin remodeler CSB to inhibit RIF1 in DSB repair pathway choice.
    Batenburg NL; Walker JR; Noordermeer SM; Moatti N; Durocher D; Zhu XD
    Nat Commun; 2017 Dec; 8(1):1921. PubMed ID: 29203878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1.
    Bakr A; Köcher S; Volquardsen J; Petersen C; Borgmann K; Dikomey E; Rothkamm K; Mansour WY
    Oncotarget; 2016 Sep; 7(36):57679-57693. PubMed ID: 27494840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.
    Sivanand S; Rhoades S; Jiang Q; Lee JV; Benci J; Zhang J; Yuan S; Viney I; Zhao S; Carrer A; Bennett MJ; Minn AJ; Weljie AM; Greenberg RA; Wellen KE
    Mol Cell; 2017 Jul; 67(2):252-265.e6. PubMed ID: 28689661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.